CAMBRIDGE, Mass.--(BUSINESS WIRE)--Helicos BioSciences (NASDAQ: HLCS), a life science company focused on innovative genetic analysis technologies, announced today the first shipment of the Helicos™ Genetic Analysis System to Expression Analysis of Durham, North Carolina, the market leader in genomic analysis services. The shipment of the first-ever single molecule DNA sequencer marks an inflection point in genomic analysis and represents a major achievement in measurement science. It is the first sequencing platform on the market designed to deliver $1,000 genome performance.
